Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,900 shares, a decline of 67.8% from the October 31st total of 5,900 shares. Based on an average daily volume of 129,200 shares, the days-to-cover ratio is currently 0.0 days.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on SMMNY. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a report on Wednesday, July 31st. UBS Group cut Siemens Healthineers from a “strong-buy” rating to a “hold” rating in a research report on Thursday, September 26th.
View Our Latest Report on SMMNY
Siemens Healthineers Trading Up 1.0 %
Siemens Healthineers Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Read More
- Five stocks we like better than Siemens Healthineers
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The How And Why of Investing in Oil Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Airline Stocks – Top Airline Stocks to Buy Now
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.